Figure][1] Katherine W. Ferrara, PhD Dr. Katherine W. Ferrara is a professor of radiology at Stanford University and the ...

PET/CT offers excellent accuracy in the staging of high-risk prostate cancer (PCa), yet outcomes-based evidence of the clinical benefit remains limited. We aimed to determine whether the rates of ...

Chimeric antigen receptor (CAR)-T cell therapy has shown limited success in the treatment of solid tumors, reinforcing the need to elucidate the in vivo biodistribution of these engineered T cells.

Journal of Nuclear Medicine March 2026, jnumed.125.271704; DOI: https://doi.org/10.2967/jnumed.125.271704 ...

Journal of Nuclear Medicine March 2026, jnumed.125.271605; DOI: https://doi.org/10.2967/jnumed.125.271605 ...

Fever of unknown origin (FUO) presents a significant diagnostic challenge because of its wide range of potential causes. The role of [18F]FDG PET/CT in this complex clinical scenario is not yet fully ...

Journal of Nuclear Medicine February 2026, jnumed.125.271098; DOI: https://doi.org/10.2967/jnumed.125.271098 ...

Fibroblast activation protein (FAP) is highly expressed in many cancers, especially sarcomas, and represents a promising theranostic target. We present an updated retrospective analysis of 90Y-FAP ...

Medical imaging and nuclear medicine are fundamental techniques used in today’s health care for diagnosing and treating ...

Journal of Nuclear Medicine January 2026, jnumed.125.271039; DOI: https://doi.org/10.2967/jnumed.125.271039 ...

High expression of prostate-specific membrane antigen (PSMA) is not limited to prostate cancer but can be found in other tumor entities, such as hepatocellular carcinoma (HCC), and could possibly be ...

Journal of Nuclear Medicine September 2025, jnumed.125.270358; DOI: https://doi.org/10.2967/jnumed.125.270358 ...